ArticlePulmonary therapy2017

Safety of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis: Experience from 92 Sites in an Open-Label US Expanded Access Program.

Lisa Lancaster et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.